SCHEMBL7987683

SCHEMBL7987683

NC(=O)c1c(NC(=O)c2cccs2)ncn1Cc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.50
ADORA3 P0DMS8 1/20 0.48
ADORA2A P29274 1/20 0.48
NPC1 O15118 6/20 0.47
RAB9A P51151 6/20 0.47
SMN1; SMN2 Q16637 5/20 0.47
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
MAPK1 P28482 3/20 0.47
ALDH1A1 P00352 3/20 0.47
MAPT P10636 3/20 0.47
ABL1 P00519 2/20 0.47
TP53 P04637 1/20 0.47
NFKB1 P19838 1/20 0.47
NFKB2 Q00653 1/20 0.47
RELA Q04206 1/20 0.47
KDM4E B2RXH2 3/20 0.46
GAA P10253 1/20 0.44
PKM P14618 1/20 0.44
TSHR P16473 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7975241 0.83 GAA (0.50) LMNAADORA3ADORA2ANPC1RAB9A
SCHEMBL7985682 0.82 GAA (0.46) RAB9ASMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL7985506 0.81 GAA (0.48) ADORA3SMN1; SMN2KMT2AMAPTKDM4E
SCHEMBL7988350 0.80 GAA (0.51) LMNASMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL7988029 0.80 IDO1 (0.47) LMNAADORA3NPC1RAB9ASMN1; SMN2
SCHEMBL7992520 0.80 POLB (0.47) ADORA3NPC1RAB9ASMN1; SMN2MEN1
SCHEMBL7985255 0.79 ALDH1A1 (0.51) LMNANPC1RAB9ASMN1; SMN2MEN1
SCHEMBL7991521 0.79 ADORA3 (0.47) ADORA3NPC1RAB9ASMN1; SMN2MEN1
SCHEMBL7991565 0.78 TSHR (0.49) LMNASMN1; SMN2KMT2AMAPK1ALDH1A1
SCHEMBL7992192 0.78 HSD17B13 (0.46) SMN1; SMN2MEN1KMT2AMAPTTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed